147 related articles for article (PubMed ID: 37446060)
1. Data Normalization of Urine miRNA Profiling from Head and Neck Cancer Patients Treated with Cisplatin.
Torso NG; Quintanilha JCF; Cursino MA; Pincinato EC; Lima CSP; Moriel P
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37446060
[TBL] [Abstract][Full Text] [Related]
2. Normalization matters: tracking the best strategy for sperm miRNA quantification.
Corral-Vazquez C; Blanco J; Salas-Huetos A; Vidal F; Anton E
Mol Hum Reprod; 2017 Jan; 23(1):45-53. PubMed ID: 27932553
[TBL] [Abstract][Full Text] [Related]
3. miR-6805-5p as a biomarker of cisplatin-induced nephrotoxicity in patients with head and neck cancer.
Torso NG; Quintanilha JCF; Cursino MA; Pincinato EC; Loren P; Salazar LA; Lima CSP; Moriel P
Front Pharmacol; 2023; 14():1275238. PubMed ID: 38089043
[No Abstract] [Full Text] [Related]
4. Changes in circulating microRNAs after radiochemotherapy in head and neck cancer patients.
Summerer I; Niyazi M; Unger K; Pitea A; Zangen V; Hess J; Atkinson MJ; Belka C; Moertl S; Zitzelsberger H
Radiat Oncol; 2013 Dec; 8():296. PubMed ID: 24373621
[TBL] [Abstract][Full Text] [Related]
5. Identification of Suitable Endogenous Normalizers for qRT-PCR Analysis of Plasma microRNA Expression in Essential Hypertension.
Solayman MH; Langaee T; Patel A; El-Wakeel L; El-Hamamsy M; Badary O; Johnson JA
Mol Biotechnol; 2016 Mar; 58(3):179-87. PubMed ID: 26798072
[TBL] [Abstract][Full Text] [Related]
6. Differential microRNA expression and identification of putative miRNA targets and pathways in head and neck cancers.
Nurul-Syakima AM; Yoke-Kqueen C; Sabariah AR; Shiran MS; Singh A; Learn-Han L
Int J Mol Med; 2011 Sep; 28(3):327-36. PubMed ID: 21637912
[TBL] [Abstract][Full Text] [Related]
7. Analysis of differential expression profile of miRNA in peripheral blood of patients with lung cancer.
He Q; Fang Y; Lu F; Pan J; Wang L; Gong W; Fei F; Cui J; Zhong J; Hu R; Liang M; Fang L; Wang H; Yu M; Zhang ZF
J Clin Lab Anal; 2019 Nov; 33(9):e23003. PubMed ID: 31541491
[TBL] [Abstract][Full Text] [Related]
8. MiR-3168, miR-6125, and miR-4718 as potential predictors of cisplatin-induced nephrotoxicity in patients with head and neck cancer.
Quintanilha JCF; Cursino MA; Borges JB; Torso NG; Bastos LB; Oliveira JM; Cobaxo TS; Pincinato EC; Hirata MH; Geraldo MV; Lima CSP; Moriel P
BMC Cancer; 2021 May; 21(1):575. PubMed ID: 34011306
[TBL] [Abstract][Full Text] [Related]
9. miRNA-seq analysis of human vertebrae provides insight into the mechanism underlying GIOP.
Ren H; Yu X; Shen G; Zhang Z; Shang Q; Zhao W; Huang J; Yu P; Zhan M; Lu Y; Liang Z; Tang J; Liang D; Yao Z; Yang Z; Jiang X
Bone; 2019 Mar; 120():371-386. PubMed ID: 30503955
[TBL] [Abstract][Full Text] [Related]
10. Identification and validation of reference genes for the detection of serum microRNAs by reverse transcription-quantitative polymerase chain reaction in patients with bladder cancer.
Wang L; Liu Y; Du L; Li J; Jiang X; Zheng G; Qu A; Wang H; Wang L; Zhang X; Liu H; Pan H; Yang Y; Wang C
Mol Med Rep; 2015 Jul; 12(1):615-22. PubMed ID: 25738263
[TBL] [Abstract][Full Text] [Related]
11. miR-361-5p as a promising qRT-PCR internal control for tumor and normal breast tissues.
Ghanbari S; Salimi A; Rahmani S; Nafissi N; Sharifi-Zarchi A; Mowla SJ
PLoS One; 2021; 16(6):e0253009. PubMed ID: 34101749
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA profiling reveals dysregulated microRNAs and their target gene regulatory networks in cemento-ossifying fibroma.
Pereira TDSF; Brito JAR; Guimarães ALS; Gomes CC; de Lacerda JCT; de Castro WH; Coimbra RS; Diniz MG; Gomez RS
J Oral Pathol Med; 2018 Jan; 47(1):78-85. PubMed ID: 29032608
[TBL] [Abstract][Full Text] [Related]
13. Identification of key microRNAs associated with diffuse large B-cell lymphoma by analyzing serum microRNA expressions.
Meng Y; Quan L; Liu A
Gene; 2018 Feb; 642():205-211. PubMed ID: 29128636
[TBL] [Abstract][Full Text] [Related]
14. A Panel of MicroRNA Signature as a Tool for Predicting Survival of Patients with Urothelial Carcinoma of the Bladder.
Inamoto T; Uehara H; Akao Y; Ibuki N; Komura K; Takahara K; Takai T; Uchimoto T; Saito K; Tanda N; Yoshikawa Y; Minami K; Hirano H; Nomi H; Kato R; Hayashi T; Azuma H
Dis Markers; 2018; 2018():5468672. PubMed ID: 30026881
[TBL] [Abstract][Full Text] [Related]
15. miRNA profiling of human nasopharyngeal carcinoma cell lines HONE1 and CNE2 after X-ray therapy.
Luo H; Zhong F; Jing X; Lin H; Li Y
Adv Clin Exp Med; 2022 Jun; 31(6):671-687. PubMed ID: 35275451
[TBL] [Abstract][Full Text] [Related]
16. Dysregulated Serum MiRNA Profile and Promising Biomarkers in Dengue-infected Patients.
Ouyang X; Jiang X; Gu D; Zhang Y; Kong SK; Jiang C; Xie W
Int J Med Sci; 2016; 13(3):195-205. PubMed ID: 26941580
[TBL] [Abstract][Full Text] [Related]
17. [Bioinformatics analysis of the microRNA expression profile in the peripheral blood lymphocytes of Kazakh patients with essential hypertension in Xinjiang].
Wang Y; Zhang L; Yang R; Shan LY; Wang L; Zhang YY; Li XZ; Ma KT
Sheng Li Xue Bao; 2022 Oct; 74(5):751-762. PubMed ID: 36319098
[TBL] [Abstract][Full Text] [Related]
18. Suitable reference genes for relative quantification of miRNA expression in prostate cancer.
Schaefer A; Jung M; Miller K; Lein M; Kristiansen G; Erbersdobler A; Jung K
Exp Mol Med; 2010 Nov; 42(11):749-58. PubMed ID: 20890088
[TBL] [Abstract][Full Text] [Related]
19. Microarray data analysis on gene and miRNA expression to identify biomarkers in non-small cell lung cancer.
Jin X; Guan Y; Zhang Z; Wang H
BMC Cancer; 2020 Apr; 20(1):329. PubMed ID: 32299382
[TBL] [Abstract][Full Text] [Related]
20. Role of Host miRNA Hsa-miR-139-3p in HPV-16-Induced Carcinomas.
Sannigrahi MK; Sharma R; Singh V; Panda NK; Rattan V; Khullar M
Clin Cancer Res; 2017 Jul; 23(14):3884-3895. PubMed ID: 28143871
[No Abstract] [Full Text] [Related]
[Next] [New Search]
